[Final bedside verification: results of a national survey of reagents and devices used in France]

F Noizat-Pirenne; P Y Le Pennec; J M Lascaux; D Fraval; F Zaoui; P Rouger

doi:10.1016/s1246-7820(99)80003-2

[Final bedside verification: results of a national survey of reagents and devices used in France]

Transfus Clin Biol. 1998 Dec;5(6):392-6. doi: 10.1016/s1246-7820(99)80003-2.

[Article in French]

Authors

F Noizat-Pirenne¹, P Y Le Pennec, J M Lascaux, D Fraval, F Zaoui, P Rouger

Affiliation

¹ Centre national de référence pour les groupes sanguins, Inserm U76, Paris, France.

PMID: 9894330
DOI: 10.1016/s1246-7820(99)80003-2

Abstract

The national reference Center for blood groups checked samples of reagents and devices used in France for a definitive verification of pretransfusion ABO tests performed at the patient's bedside, as defined by French health authority regulations. The results of an initial inquiry was published in 1991. The new study shows no significant improvement of the quality of reagents and devices. This is a major concern considering the importance of ABO incompatibility in severe hemolytic transfusion reactions.

Publication types

English Abstract

MeSH terms

ABO Blood-Group System / analysis*
Blood Banking / methods
Blood Banks / statistics & numerical data*
Blood Group Incompatibility / diagnosis*
Blood Grouping and Crossmatching / instrumentation
Blood Grouping and Crossmatching / methods
Blood Grouping and Crossmatching / statistics & numerical data*
Blood Transfusion
Data Collection
Erythrocyte Transfusion
Evaluation Studies as Topic
Forms and Records Control
France
Humans
Indicators and Reagents
Medical Records
Reproducibility of Results
Safety

Substances

ABO Blood-Group System
Indicators and Reagents